) from Hold to Sell, while reducing the price target from $93 to $61. Hill believes that there could be downside risk of 11 percent to the stock, from the current levels. "Given the acrimony between ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

The MarketWatch News Department was not involved in the creation of this content. Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates ...

Sources told Reuters that the deal is modeled on a similar agreement inked between FTC and Cigna’s pharmacy benefit manager ...

Cigna signed a definitive agreement to acquire Express Scripts for $67 billion in cash and stock, including assumption of $15 billion in Express Scripts debt. Here are five things to know about the ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

Hours after a class-action lawsuit was filed in Cambria County court, on behalf of Martella's Pharmacies and its customers, a judge has ordered a temporary hold on the PBM Express Scripts and its plan ...

NEW YORK – Pharmacy benefit manager Caremark Rx (CMX) said late on Sunday it had rejected a roughly $26 billion takeover bid from rival Express Scripts, saying it favored an offer of about $22.2 ...